Literature DB >> 16093828

New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells.

Harini Bagavant1, Shu Man Fu.   

Abstract

PURPOSE OF REVIEW: This review summarizes current literature on genetic regulation of different phenotypes in systemic lupus erythematosus in context of end-organ disease. Recent findings conflicting with the current paradigm that loss of tolerance to chromatin is the critical step for end-organ injury are discussed. RECENT
FINDINGS: Systemic lupus erythematosus is a prototype immune complex disease with circulating autoantibodies to chromatin, histone proteins, Sm/La, and other nuclear and cytoplasmic proteins. Extensive studies have been carried out on the regulation of B-cell and autoantibody production in lupus mice. However, the hypothesis that autoantibodies are primary mediators of organ damage fails to explain the heterogenous presentation in patients. Studies in murine models of systemic lupus erythematosus clearly dissociate genetic control of autoantibody responses to classic lupus antigens and kidney disease. There is increasing evidence to support the role of autoreactive T cells and genetic control of end organ susceptibility. These studies suggest complex interactions between innate and adaptive immunity resulting in end-organ damage. This review focuses on autoimmune responses and renal involvement in spontaneous systemic lupus erythematosus using murine models of lupus nephritis.
SUMMARY: Studies in murine models demonstrate complex genetic interactions regulating spontaneous systemic lupus erythematosus. Although detection of serum autoantibodies is considered a hallmark for clinical diagnosis of systemic lupus erythematosus, recent evidence shows that autoantibodies to classic lupus antigens are neither required nor sufficient for end-organ damage. Thus, murine models provide new insights into the pathogenesis of systemic lupus erythematosus.

Entities:  

Mesh:

Year:  2005        PMID: 16093828     DOI: 10.1097/01.bor.0000169361.23325.1e

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  12 in total

1.  Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice.

Authors:  Ramalingam Bethunaickan; Celine C Berthier; Weijia Zhang; Ridvan Eksi; Hong-Dong Li; Yuanfang Guan; Matthias Kretzler; Anne Davidson
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

2.  Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background.

Authors:  S Rashtak; E Marietta; S Cheng; M Camilleri; M Pittelkow; C David; J Grande; J Murray
Journal:  Lupus       Date:  2010-02-08       Impact factor: 2.911

3.  Immunologic characteristics of intrarenal T cells: trafficking of expanded CD8+ T cell β-chain clonotypes in progressive lupus nephritis.

Authors:  Robert Winchester; Margrit Wiesendanger; Hui-Zhu Zhang; Valeria Steshenko; Karin Peterson; Laura Geraldino-Pardilla; Elena Ruiz-Vazquez; Vivette D'Agati
Journal:  Arthritis Rheum       Date:  2012-05

4.  Longevity of SLE-prone mice increased by dietary 2-mercaptoethanol via a mechanism imprinted within the first 28 days of life.

Authors:  Robert E Click
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

5.  Genetic approach to study lupus glomerulonephritis.

Authors:  Yan Ge; Michael G Brown; Hongyang Wang; Shu Man Fu
Journal:  Methods Mol Biol       Date:  2012

6.  Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency.

Authors:  Florencia Rosetti; Naotake Tsuboi; Kan Chen; Hiroshi Nishi; Thomas Ernandez; Sanjeev Sethi; Kevin Croce; George Stavrakis; Jorge Alcocer-Varela; Diana Gómez-Martin; Nico van Rooijen; Vasileios C Kyttaris; Andrew H Lichtman; George C Tsokos; Tanya N Mayadas
Journal:  J Immunol       Date:  2012-08-29       Impact factor: 5.422

7.  The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Authors:  Seth G Thacker; Celine C Berthier; Deborah Mattinzoli; Maria Pia Rastaldi; Matthias Kretzler; Mariana J Kaplan
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

8.  Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice.

Authors:  Patrizia Scapini; Yongmei Hu; Ching-Liang Chu; Thi-Sau Migone; Anthony L Defranco; Marco A Cassatella; Clifford A Lowell
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

9.  SPARC regulation of PMN clearance protects from pristane-induced lupus and rheumatoid arthritis.

Authors:  Sabina Sangaletti; Laura Botti; Alessandro Gulino; Daniele Lecis; Barbara Bassani; Paola Portararo; Matteo Milani; Valeria Cancila; Loris De Cecco; Matteo Dugo; Claudio Tripodo; Mario P Colombo
Journal:  iScience       Date:  2021-05-04

Review 10.  Current status of lupus genetics.

Authors:  Andrea L Sestak; Swapan K Nath; Amr H Sawalha; John B Harley
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.